103 related articles for article (PubMed ID: 37282766)
21. Modeling SARS-CoV-2: Comparative Pathology in Rhesus Macaque and Golden Syrian Hamster Models.
Choudhary S; Kanevsky I; Yildiz S; Sellers RS; Swanson KA; Franks T; Rathnasinghe R; Munoz-Moreno R; Jangra S; Gonzalez O; Meade P; Coskran T; Qian J; Lanz TA; Johnson JG; Tierney CA; Smith JD; Tompkins K; Illenberger A; Corts P; Ciolino T; Dormitzer PR; Dick EJ; Shivanna V; Hall-Ursone S; Cole J; Kaushal D; Fontenot JA; Martinez-Romero C; McMahon M; Krammer F; Schotsaert M; García-Sastre A
Toxicol Pathol; 2022 Apr; 50(3):280-293. PubMed ID: 35128980
[TBL] [Abstract][Full Text] [Related]
22. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
Elife; 2022 Feb; 11():. PubMed ID: 35191378
[TBL] [Abstract][Full Text] [Related]
23. B.1.351 SARS-CoV-2 Variant Exhibits Higher Virulence but Less Viral Shedding than That of the Ancestral Strain in Young Nonhuman Primates.
Bai Y; He Q; Yang J; Lu S; Mao Q; Gao F; Bian L; Zhang J; An C; Liu J; Wu X; Yu W; Wang Z; Peng X; Wang J; Liang Z; Xu M
Microbiol Spectr; 2022 Oct; 10(5):e0226322. PubMed ID: 36069561
[TBL] [Abstract][Full Text] [Related]
24. Histopathological pulmonary lesions in rhesus (Macaca mulatta) and cynomolgus (Macaca fascicularis) macaques experimentally infected with wild-type severe acute respiratory syndrome coronavirus 2.
Oh T; Hong JJ; Park JH
J Comp Pathol; 2024 Jan; 208():5-10. PubMed ID: 38007889
[TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2 bivalent mRNA vaccine with broad protection against variants of concern.
Ma Q; Li M; Ma L; Zhang C; Zhang H; Zhong H; Wen J; Wang Y; Yan Z; Xiong W; Wu L; Guo J; Yang W; Yang Z; Zhang B
Front Immunol; 2023; 14():1195299. PubMed ID: 37292197
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic efficacy of monoclonal antibodies and antivirals against SARS-CoV-2 Omicron BA.1 in Syrian hamsters.
Uraki R; Kiso M; Imai M; Yamayoshi S; Ito M; Fujisaki S; Takashita E; Ujie M; Furusawa Y; Yasuhara A; Iwatsuki-Horimoto K; Sakai-Tagawa Y; Watanabe S; Hasegawa H; Kawaoka Y
Nat Microbiol; 2022 Aug; 7(8):1252-1258. PubMed ID: 35705860
[TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo differences in neurovirulence between D614G, Delta And Omicron BA.1 SARS-CoV-2 variants.
Bauer L; Rissmann M; Benavides FFW; Leijten L; van Run P; Begeman L; Veldhuis Kroeze EJB; Lendemeijer B; Smeenk H; de Vrij FMS; Kushner SA; Koopmans MPG; Rockx B; van Riel D
Acta Neuropathol Commun; 2022 Sep; 10(1):124. PubMed ID: 36058935
[TBL] [Abstract][Full Text] [Related]
28. A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection.
Abdelnabi R; Foo CS; Kaptein SJF; Boudewijns R; Vangeel L; De Jonghe S; Jochmans D; Weynand B; Neyts J
J Virol; 2022 Aug; 96(16):e0075822. PubMed ID: 35924921
[TBL] [Abstract][Full Text] [Related]
29. Sequential immunizations confer cross-protection against variants of SARS-CoV-2, including Omicron in Rhesus macaques.
Deng W; Lv Q; Li F; Liu J; Song Z; Qi F; Wei Q; Yu P; Liu M; Zhou S; Zhang Y; Gao H; Wang N; Jia Z; Gao K; Liu J; Xiao C; Shang H; Wang X; Bao L; Qin C
Signal Transduct Target Ther; 2022 Apr; 7(1):124. PubMed ID: 35436986
[TBL] [Abstract][Full Text] [Related]
30. COVID-19: Omicron - the latest, the least virulent, but probably not the last variant of concern of SARS-CoV-2.
Brüssow H
Microb Biotechnol; 2022 Jul; 15(7):1927-1939. PubMed ID: 35443078
[TBL] [Abstract][Full Text] [Related]
31. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
[TBL] [Abstract][Full Text] [Related]
32. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW
mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750
[TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo.
Hui KPY; Ho JCW; Cheung MC; Ng KC; Ching RHH; Lai KL; Kam TT; Gu H; Sit KY; Hsin MKY; Au TWK; Poon LLM; Peiris M; Nicholls JM; Chan MCW
Nature; 2022 Mar; 603(7902):715-720. PubMed ID: 35104836
[TBL] [Abstract][Full Text] [Related]
34. The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters.
Diamond M; Halfmann P; Maemura T; Iwatsuki-Horimoto K; Iida S; Kiso M; Scheaffer S; Darling T; Joshi A; Loeber S; Foster S; Ying B; Whitener B; Floyd K; Ujie M; Nakajima N; Ito M; Wright R; Uraki R; Li R; Sakai Y; Liu Y; Larson D; Osorio J; Hernandez-Ortiz J; Čiuoderis K; Florek K; Patel M; Bateman A; Odle A; Wong LY; Wang Z; Edara VV; Chong Z; Thackray L; Ueki H; Yamayoshi S; Imai M; Perlman S; Webby R; Seder R; Suthar M; Garcia-Sastre A; Schotsaert M; Suzuki T; Boon A; Kawaoka Y; Douek D; Moliva J; Sullivan N; Gagne M; Ransier A; Case J; Jeevan T; Franks J; Fabrizio T; DeBeauchamp J; Kercher L; Seiler P; Singh G; Warang P; Gonzalez-Reiche AS; Sordillo E; van Bakel H; Simon V
Res Sq; 2021 Dec; ():. PubMed ID: 34981044
[TBL] [Abstract][Full Text] [Related]
35. TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection.
Metzdorf K; Jacobsen H; Greweling-Pils MC; Hoffmann M; Lüddecke T; Miller F; Melcher L; Kempf AM; Nehlmeier I; Bruder D; Widera M; Ciesek S; Pöhlmann S; Čičin-Šain L
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851486
[TBL] [Abstract][Full Text] [Related]
36. Different pathogenesis of SARS-CoV-2 Omicron variant in wild-type laboratory mice and hamsters.
Zhang YN; Zhang ZR; Zhang HQ; Li N; Zhang QY; Li XD; Deng CL; Deng F; Shen S; Zhu B; Zhang B
Signal Transduct Target Ther; 2022 Feb; 7(1):62. PubMed ID: 35217641
[No Abstract] [Full Text] [Related]
37. RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge.
Shi J; Zheng J; Zhang X; Tai W; Odle AE; Perlman S; Du L
Transl Res; 2022 Oct; 248():11-21. PubMed ID: 35489692
[TBL] [Abstract][Full Text] [Related]
38. Tuning the immune response: sulfated archaeal glycolipid archaeosomes as an effective vaccine adjuvant for induction of humoral and cell-mediated immunity towards the SARS-CoV-2 Omicron variant of concern.
Renner TM; Akache B; Stuible M; Rohani N; Cepero-Donates Y; Deschatelets L; Dudani R; Harrison BA; Baardsnes J; Koyuturk I; Hill JJ; Hemraz UD; Régnier S; Lenferink AEG; Durocher Y; McCluskie MJ
Front Immunol; 2023; 14():1182556. PubMed ID: 37122746
[TBL] [Abstract][Full Text] [Related]
39. Do we need nasal vaccines against COVID 19 to suppress the transmission of infections?
Brüssow H
Microb Biotechnol; 2023 Jan; 16(1):3-14. PubMed ID: 36464938
[TBL] [Abstract][Full Text] [Related]
40. Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike.
Yamasoba D; Kimura I; Nasser H; Morioka Y; Nao N; Ito J; Uriu K; Tsuda M; Zahradnik J; Shirakawa K; Suzuki R; Kishimoto M; Kosugi Y; Kobiyama K; Hara T; Toyoda M; Tanaka YL; Butlertanaka EP; Shimizu R; Ito H; Wang L; Oda Y; Orba Y; Sasaki M; Nagata K; Yoshimatsu K; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; Kuramochi J; Seki M; Fujiki R; Kaneda A; Shimada T; Nakada TA; Sakao S; Suzuki T; Ueno T; Takaori-Kondo A; Ishii KJ; Schreiber G; ; Sawa H; Saito A; Irie T; Tanaka S; Matsuno K; Fukuhara T; Ikeda T; Sato K
Cell; 2022 Jun; 185(12):2103-2115.e19. PubMed ID: 35568035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]